Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Parathyroid Carcinoma on the Basis of Isolated Familial Hyperparathyroidism

Dr Semiha Calkaya, Dr Fahri Bayram

Parathyroid carcinoma is a very rare endocrine neoplasm which results high production of parathyroid hormone (PTH) responsible for pathologic high calcium levels resulting in bone pain/fractures, renal disease and other signs of hypercalcemia. Clinically the disease is detected in patients earlier important because the morbidity and mortality are significant and the best prognosis is associated with early diagnosis and surgical resection.

Here, we present a rare case of familial hyperparathyroidism in which he and his two sons were diagnosed. We report a case of a 59 year old male who presented to our hospital with persistent hyperparathyroidism and hypercalcemia 6 years after having undergone total of two parathyroidectomy operations in this hospital and another.

Development of parathyroid carcınoma in isolated familial primary hyperparathyroidism should be kept in mind. The primary treatment of parathyroid carcinoma on the basis of isolated familial hyperparathyroidism is surgery. When the tumor is no longer amenable to surgical intervention, treatment becomes focused on the control of hypercalcemia with medical therapy, which can include bisphosphonates, calcimimetic agents, or denosumab.